Answers are grounded in this paper and cite their sources.
Figure reveals tumor subtype is unchanged by TGF-beta pathway modifications in breast cancer, highlighting its role in morphology.
Supplementary Figure 14 shows that tumor IHC subtype is not affected by TGF-beta pathway modifications.
No takes yet. Share an insight, caveat, or question.
Lutz et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: